Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level
Veena Somasundaram,
Anne C. Gilmore,
Debashree Basudhar,
Erika Mariana Palmieri,
David A. Scheiblin,
William F. Heinz,
Robert.Y.S. Cheng,
Lisa A. Ridnour,
Grégoire Altan-Bonnet,
Stephen J. Lockett,
Daniel W. McVicar,
David A. Wink
Affiliations
Veena Somasundaram
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institute of Health, USA
Anne C. Gilmore
Optical Microscopy and Analysis Laboratory, Office of Science and Technology Resources, Center for Cancer Research, National Cancer Institute, USA
Debashree Basudhar
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institute of Health, USA
Erika Mariana Palmieri
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institute of Health, USA
David A. Scheiblin
Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
William F. Heinz
Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
Robert.Y.S. Cheng
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institute of Health, USA
Lisa A. Ridnour
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institute of Health, USA
Grégoire Altan-Bonnet
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institute of Health, USA
Stephen J. Lockett
Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
Daniel W. McVicar
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institute of Health, USA
David A. Wink
Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institute of Health, USA; Corresponding author. Cancer and Inflammation Program, National Cancer Institute, NIH, Frederick, MD, 21702, NCI-Frederick, USA.
The role of nitric oxide (NO) in cancer progression has largely been studied in the context of tumor NOS2 expression. However, pro- versus anti-tumor signaling is also affected by tumor cell-macrophage interactions. While these cell-cell interactions are partly regulated by NO, the functional effects of NO flux on proinflammatory (M1) macrophages are unknown. Using a triple negative murine breast cancer model, we explored the potential role of macrophage Nos2 on 4T1 tumor progression. The effects of NO on macrophage phenotype were examined in bone marrow derived macrophages from wild type and Nos2−/− mice following in vitro stimulation with cytokine/LPS combinations to produce low, medium, and high NO flux. Remarkably, Nos2 induction was spatially distinct, where Nos2high cells expressed low cyclooxygenase-2 (Cox2) and vice versa. Importantly, in vitro M1 polarization with IFNγ+LPS induced high NO flux that was restricted to cells harboring depolarized mitochondria. This flux altered the magnitude and spatial extent of hypoxic gradients. Metabolic and single cell analyses demonstrated that single cell Nos2 induction limited the generation of hypoxic gradients in vitro, and Nos2-dependent and independent features may collaborate to regulate M1 functionality. It was found that Cox2 expression was important for Nos2high cells to maintain NO tolerance. Furthermore, Nos2 and Cox2 expression in 4T1 mouse tumors was spatially orthogonal forming distinct cellular neighborhoods. In summary, the location and type of Nos2high cells, NO flux, and the inflammatory status of other cells, such as Cox2high cells in the tumor niche contribute to Nos2 inflammatory mechanisms that promote disease progression of 4T1 tumors. Keywords: Nos2, Macrophage, Tumor, Metabolism